Transcriptomics involves the study of the RNA transcripts produced by the genome. It provides insights into gene expression patterns and how they change in cancerous cells. Transcriptomic data can reveal dysregulated pathways and potential therapeutic targets. Technologies like RNA-Seq have been instrumental in identifying novel fusion genes and non-coding RNAs involved in cancer.
